rs12722 — COL5A1 C/T 3'UTR

Collagen fibril assembly variant linked to soft tissue injury risk and tendon flexibility

See your personal result for COL5A1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

COL5A1 — The Collagen Blueprint Behind Tendon Strength

Your tendons and ligaments are built from collagen fibrils — rope-like protein structures that give connective tissue its strength and elasticity. Type V collagen, encoded by the COL5A1 gene, acts as a master regulator of this construction process. It controls how thick individual collagen fibrils11 collagen fibrils
microscopic protein cables that bundle together to form tendons, ligaments, and other connective tissues grow by embedding within larger type I collagen fibrils and limiting their lateral expansion. The rs12722 variant sits in the 3'UTR22 3'UTR
the 3' untranslated region of mRNA, which regulates how stable the mRNA molecule is and how much protein gets made from it of COL5A1, where it alters how much type V collagen your cells produce.

The Mechanism

The C-to-T change at rs12722 affects mRNA stability rather than protein structure. Functional studies33 Functional studies
Laguette et al. Sequence variants within the 3'-UTR of the COL5A1 gene alters mRNA stability. Matrix Biology, 2011 demonstrated that the T allele produces more stable mRNA transcripts, which leads to increased production of the type V collagen alpha-1 chain. While more collagen might sound beneficial, an excess of type V collagen actually disrupts the normal fibril assembly process. The resulting fibrils may have altered diameter and spacing, changing the mechanical properties of tendons and ligaments — making them stiffer and potentially more prone to injury under repetitive loading.

This mechanism also helps explain why the variant influences range of motion44 range of motion
Brown et al. The COL5A1 genotype is associated with range of motion measurements. Scand J Med Sci Sports, 2011: individuals with the CC genotype tend to have greater joint flexibility, while TT carriers have stiffer connective tissue and reduced range of motion.

The Evidence

The association between rs12722 and soft tissue injuries has been examined in multiple studies and meta-analyses:

  • The original discovery55 original discovery
    Mokone et al. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports, 2006     found that the C allele (here called A2) was significantly more common in healthy controls than in patients with chronic Achilles tendinopathy (29.8% vs 18.0%, OR 1.9).
  • September et al.66 September et al.
    September et al. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br J Sports Med, 2009     replicated the finding in a second independent population, strengthening the evidence.
  • A 2018 meta-analysis of 9 studies77 2018 meta-analysis of 9 studies
    Lv et al. Association between polymorphism rs12722 in COL5A1 and musculoskeletal soft tissue injuries: a systematic review and meta-analysis. Oncotarget, 2018     (1,140 cases, 1,410 controls) found TT carriers had 58% higher risk of soft tissue injuries compared to CT/CC carriers (OR 1.58, 95% CI 1.33-1.89). When broken down by injury type: tennis elbow OR 2.06, ACL injuries OR 1.53, Achilles tendon pathology OR 1.48.
  • The largest meta-analysis to date88 largest meta-analysis to date
    Guo et al. Association of COL5A1 gene polymorphisms and musculoskeletal soft tissue injuries: a meta-analysis based on 21 observational studies. J Orthop Surg Res, 2022     (2,164 cases, 5,079 controls) confirmed the association with an allelic OR of 1.14 and homozygous (TT vs CC) OR of 1.33, driven primarily by ligament injuries in Caucasian populations.

Importantly, the association appears strongest in Caucasian populations and for ligament injuries specifically. Studies in East Asian populations have generally not found significant associations, which may reflect both the lower T allele frequency in those populations (~17% vs ~58% in Europeans) and potential gene-environment differences.

Practical Implications

The TT genotype increases injury risk under a recessive model — carrying one T allele (CT) confers only modestly elevated risk, while two copies (TT) is where the meaningful increase begins. If you carry TT, this does not mean injury is inevitable. It means your connective tissue may be less resilient to repetitive strain, and proactive measures — adequate warm-up, progressive training loads, eccentric strengthening exercises, and collagen-supportive nutrition — become more important.

The C allele appears protective for flexibility and injury resistance. CC carriers tend to have greater range of motion and lower baseline risk for tendon and ligament injuries.

Interactions

The rs12722 variant interacts with other COL5A1 polymorphisms. The nearby rs13946 variant (also in the 3'UTR) has been studied alongside rs12722, and haplotype analysis suggests their combined effect may further modulate injury risk. The rs3196378 variant in the same gene has also shown independent associations with soft tissue injury susceptibility. Additionally, variants in other collagen genes (COL1A1, COL11A1, COL11A2) may compound the effect on connective tissue properties.

Genotype Interpretations

What each possible genotype means for this variant.

CC Resilient Tendons Normal

Lower risk of soft tissue injuries with greater flexibility

The CC genotype produces less stable COL5A1 mRNA compared to CT or TT genotypes, resulting in lower levels of type V collagen in connective tissues. Since type V collagen acts as a limiter of fibril diameter, lower production leads to normal or slightly larger collagen fibrils, which tend to produce more compliant (flexible) tendons and ligaments.

In multiple studies, CC carriers have been the reference group with the lowest incidence of chronic Achilles tendinopathy, ACL ruptures, and other soft tissue injuries. A meta-analysis of 2,164 cases and 5,079 controls confirmed that CC carriers have significantly lower odds of musculoskeletal injury compared to TT carriers (OR 0.75, inverse of TT vs CC OR 1.33).

CT Moderate Flexibility Intermediate

One copy of the collagen variant — modestly elevated injury risk

Heterozygous CT carriers produce an intermediate amount of type V collagen. The T allele generates more stable mRNA than the C allele, so CT individuals produce somewhat more type V collagen than CC carriers, but less than TT homozygotes. This leads to intermediate collagen fibril properties.

In the recessive model that best fits the data, CT carriers group with CC carriers as the lower-risk category. The 2018 meta-analysis (Lv et al.) found no significant difference between CT and CC genotypes (OR 1.24, 95% CI 0.92-1.67, P=0.15). However, the 2022 meta-analysis (Guo et al.) with a larger dataset found a modest but significant difference in a dominant model (TT+CT vs CC: OR 1.28), suggesting CT carriers do carry some elevated risk compared to CC.

TT Stiffer Tendons High Risk

Elevated risk of soft tissue injuries — proactive prevention recommended

The TT genotype leads to the most stable COL5A1 mRNA and the highest production of type V collagen. Excess type V collagen integrates into growing collagen fibrils and restricts their lateral growth, resulting in thinner, more densely packed fibrils. This altered fibril architecture makes tendons and ligaments stiffer and less compliant, reducing their ability to absorb and distribute mechanical stress.

The largest meta-analysis (Guo et al. 2022, 21 studies, 2,164 cases, 5,079 controls) confirmed that TT carriers face significantly higher odds of musculoskeletal injury (TT vs CC: OR 1.33, 95% CI 1.08-1.65). The earlier Lv et al. 2018 meta-analysis found an even stronger effect in the recessive model (OR 1.58, 95% CI 1.33-1.89). The association is driven primarily by ligament injuries and is strongest in Caucasian populations.

It is important to note that this is a risk factor, not a deterministic finding. Many TT carriers never experience tendon or ligament injuries, particularly if they train sensibly and maintain good connective tissue health. Conversely, injury prevention strategies become especially valuable for TT carriers engaged in high-impact or repetitive-loading sports.